2010 to 2019 Saw Early Palliative Care Billing Up for Advanced Cancer
By Elana Gotkine HealthDay Reporter
MONDAY, March 17, 2025 -- For patients with distant-stage cancers, there was an increase in early palliative care (PC) billing from 2010 to 2019, but the level remained low, according to a study published online March 7 in the Journal of Clinical Oncology.
Xin Hu, Ph.D., from the Emory University School of Medicine in Atlanta, and colleagues examined early PC billing, which was identified by diagnosis codes or hospice and palliative medicine (HPM) specialty codes on outpatient claims within the first three months of cancer diagnosis or up to hospice admission date. The study cohort included Medicare Fee-for-Service beneficiaries aged 65.5 years and older diagnosed with distant-stage female breast, colorectal, non-small cell lung, small cell lung, pancreatic, or prostate cancers in 2010 to 2019 with survival of at least six months.
The researchers found that in 2010 to 2019, there was an increase in the percentage with early PC billing among 102,032 patients treated by 18,908 unique physicians, from 1.44 to 10.36 percent. The likelihood of early PC billing was increased in association with treating physician's early PC referrals in the previous year and organizations' employment of any HPM specialist (3.01 and 4.54 percentage points, respectively). There was a decline seen in between-provider variation in early PC from 51 percent in 2010-2013 to 45.3 percent in 2017-2019. For between-organization variation, patterns were similar.
"Variation across providers and organizations was considerable despite a declining trend in the past decade," the authors write. "In particular, physician referral patterns and the presence of PC specialists in an organization were key drivers of early PC billing."
Two authors disclosed ties to MJH Life Sciences and Flatiron Health.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Race Definitions Have Limited Impact on Cancer Rates in Whites, Blacks, Asians
MONDAY, July 21, 2025 -- Race definitions have limited impact on cancer rates for Whites, Blacks, and Asians, but do impact rates in multiracial individuals, according to a study...
Updated Guidance Improves Staging of HPV-Positive Oropharyngeal Cancer
MONDAY, July 21, 2025 -- Version nine of the American Joint Committee on Cancer (AJCC) and Union for International Cancer Control staging system (AJCC9V) human papillomavirus...
ENDO: 1999 to 2020 Saw Significant Uptick in Obesity-Related Cancer Deaths
MONDAY, July 14, 2025 -- From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.